Stablecoin Development Corp. (SDEV)
1.54
-0.45
(-22.61%)
USD |
NYAM |
Oct 09, 16:00
1.54
0.00 (0.00%)
After-Hours: 20:00
Stablecoin Development Net Income (Quarterly) : -41.07M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -41.07M |
| March 31, 2026 | 552.40M |
| September 30, 2025 | -1.333M |
| June 30, 2025 | -1.964M |
| March 31, 2025 | -3.33M |
| December 31, 2024 | -1.898M |
| September 30, 2024 | -1.854M |
| June 30, 2024 | -2.149M |
| March 31, 2024 | -2.925M |
| December 31, 2023 | -1.719M |
| September 30, 2023 | -1.353M |
| June 30, 2023 | -1.728M |
| March 31, 2023 | -1.345M |
| December 31, 2022 | -8.206M |
| September 30, 2022 | -0.136M |
| June 30, 2022 | -2.155M |
| March 31, 2022 | -0.111M |
| December 31, 2021 | -0.159M |
| September 30, 2021 | -2.289M |
| June 30, 2021 | -1.859M |
| March 31, 2021 | -1.518M |
| December 31, 2020 | -1.754M |
| September 30, 2020 | -3.221M |
| June 30, 2020 | -4.482M |
| March 31, 2020 | -1.582M |
| Date | Value |
|---|---|
| December 31, 2019 | -2.686M |
| September 30, 2019 | -0.282M |
| June 30, 2019 | -2.53M |
| March 31, 2019 | -4.189M |
| December 31, 2018 | -1.268M |
| September 30, 2018 | -1.538M |
| June 30, 2018 | -1.589M |
| March 31, 2018 | -2.15M |
| December 31, 2017 | 0.793M |
| September 30, 2017 | -2.447M |
| June 30, 2017 | -1.738M |
| March 31, 2017 | -4.011M |
| December 31, 2016 | -1.648M |
| September 30, 2016 | -3.736M |
| June 30, 2016 | -2.69M |
| March 31, 2016 | -5.077M |
| December 31, 2015 | -4.204M |
| September 30, 2015 | -5.242M |
| June 30, 2015 | -4.887M |
| March 31, 2015 | -4.64M |
| December 31, 2014 | -4.468M |
| September 30, 2014 | -4.219M |
| June 30, 2014 | -2.942M |
| March 31, 2014 | -3.565M |
| December 31, 2013 | -4.137M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.206M |
| Total Expenses (Quarterly) | 43.28M |
| EPS Diluted (Quarterly) | -1.323 |
| Enterprise Value | 70.79M |
| Profit Margin (Quarterly) | -1.86K% |
| Earnings Yield | -48.09% |
| Normalized Earnings Yield | -137.18 |